Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

See all formats and pricing
More options …
Volume 39, Issue 8


Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease

Olaf Stanger / Martin Weger / Wilfried Renner / Ricarda Konetschny
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2001.121


Elevated plasma homocyst(e)ine is currently accepted as a major, independent risk factor for atherosclerosis and venous thrombosis. Even moderate hyperhomocyst( e)inemia is prospectively associated with increased risk of mortality in patients with cardiovascular disease. However, the underlying mechanisms resulting in vascular damage are not clearly defined.

The endothelium exerts fundamental control on the vascular tone, coagulation and fibrinolysis. Injury to the endothelium followed by dysfunction is an early key event preceding manifestation of vessel pathology. Acute and chronic exposure of endothelium to homocyst(e)ine induces impairment of endothelial function associated with altered homeostasis and morphologic changes of the vessel wall.

Investigations of the role of homocyst(e)ine in the endothelium-dependent function in healthy subjects and cardiovascular patients have recently added important clinical insight with implications for the treatment of cardiovascular disease. Importantly, the damaging effects of hyperhomocyst(e)inemia on endothelial function are, at least in part, reversible in patients with established vascular disease, supporting further the hypothesis that homocyst(e)ine-lowering through vitamin supplementation may have vasoprotective effects.

About the article

Published Online: 2005-06-01

Published in Print: 2001-08-31

Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 39, Issue 8, Pages 725–733, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2001.121.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Mai A. Abd-Elmawla, Sherine M. Rizk, Ilham Youssry, Amira A. Shaheen, and Reza Khodarahmi
PLOS ONE, 2016, Volume 11, Number 5, Page e0155070
C. Bickel, R.B. Schnabel, E. Zengin, E. Lubos, H. Rupprecht, K. Lackner, C. Proust, D. Tregouet, S. Blankenberg, D. Westermann, and C. Sinning
Nutrition, Metabolism and Cardiovascular Diseases, 2017, Volume 27, Number 2, Page 168
Paula G. Heller, Alessandro Pecci, Ana C. Glembotsky, Anna Savoia, Fernando D. Negro, Carlo L. Balduini, and Felisa C. Molinas
Platelets, 2006, Volume 17, Number 4, Page 274
E. Ruud, H. Holmstrøm, F. Brosstad, and F. Wesenberg
Scandinavian Journal of Clinical and Laboratory Investigation, 2006, Volume 66, Number 1, Page 67
Bradley L. Urquhart, David J. Freeman, J. David Spence, and Andrew A. House
The Journal of Clinical Pharmacology, 2007, Volume 47, Number 8, Page 991
Yajing Wang, Lianyun Wang, Xiaojie Ai, Jianli Zhao, Xiangfang Hao, Yutong Lu, and Zhongdong Qiao
International Immunopharmacology, 2004, Volume 4, Number 13, Page 1675
A Hakki, H Friedman, and S Pross
International Immunopharmacology, 2002, Volume 2, Number 10, Page 1403
Bradley L. Urquhart, David J. Freeman, J. David Spence, and Andrew A. House
American Journal of Kidney Diseases, 2007, Volume 49, Number 1, Page 109
Martin Weger, Olaf Stanger, Hannes Deutschmann, Franz Josef Leitner, Wilfried Renner, Otto Schmut, Jürgen Semmelrock, and Anton Haas
American Journal of Ophthalmology, 2002, Volume 134, Number 1, Page 57
Radjesh J. Bisoendial, G. Kees Hovingh, Eric de Groot, John J.P. Kastelein, Peter J. Lansberg, and Erik S.G. Stroes
Current Opinion in Lipidology, 2002, Volume 13, Number 6, Page 595
Stefano Zoccolella, Caterina Bendotti, Ettore Beghi, and Giancarlo Logroscino
Amyotrophic Lateral Sclerosis, 2010, Volume 11, Number 1-2, Page 140
Olaf Stanger and Martin Weger
Clinical Chemistry and Laboratory Medicine, 2003, Volume 41, Number 11
Olaf Stanger, Martin Weger, Rima Obeid, Werner Temmel, Andreas Meinitzer, Iris Steinbrugger, Otto Schmut, and Wolfgang Herrmann
Clinical Chemistry and Laboratory Medicine (CCLM), 2005, Volume 43, Number 10
Jens Weingaertner, Jochen Fanghaenel, Volker Bienengraeber, and Karsten K.H. Gundlach
Journal of Cranio-Maxillofacial Surgery, 2005, Volume 33, Number 5, Page 297
Nieves Díez, Raquel Pérez, Verónica Hurtado, and Santiago Santidrián
British Journal of Nutrition, 2005, Volume 94, Number 02, Page 204
Barbara Giambene, Andrea Sodi, Francesco Sofi, Rossella Marcucci, Sandra Fedi, Rosanna Abbate, Domenico Prisco, and Ugo Menchini
Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, Volume 247, Number 5, Page 693
M. Kuntay Kokanalı, Demet Öztürkkan, Naim Ünsal, Perran Möroy, Tayfun Güngör, and Leyla Mollamahmutoğlu
Archives of Gynecology and Obstetrics, 2008, Volume 278, Number 6, Page 531
Gunhal Kamburoglu, Koray Gumus, Sibel Kadayıfcılar, and Bora Eldem
Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, Volume 244, Number 5, Page 565
B Akoglu, M Schrott, H Bolouri, A Jaffari, E Kutschera, W F Caspary, and D Faust
European Journal of Clinical Nutrition, 2008, Volume 62, Number 6, Page 796
B Akoglu, P Kindl, N Weber, J Trojan, W F Caspary, and D Faust
European Journal of Clinical Nutrition, 2008, Volume 62, Number 3, Page 430

Comments (0)

Please log in or register to comment.
Log in